Want to see IN:KRSNAA full AI Analyst Report?
KRSNAA Stock Chart & Stats
₹559.25
-₹2.45(-0.45%)
At close: 4:00 PM EDT
₹559.25
-₹2.45(-0.45%)
Day’s Range― - ―
52-Week Range₹502.20 - ₹891.80
Previous CloseN/A
Volume72.45K
Average Volume (3M)11.99K
Market Cap
₹18.11B
Enterprise Value₹18.85K
Total Cash (Recent Filing)₹3.61B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)18.6
Beta0.94
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.36%
Share Statistics
EPS (TTM)30.04
Shares Outstanding32,438,670
10 Day Avg. Volume22,205
30 Day Avg. Volume11,994
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)1.72
Price to Sales (P/S)2.18
P/FCF Ratio-17.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)38.47
Revenue Forecast (FY)₹10.02B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained revenue expansion indicates continued demand for pathology and imaging services. Growth across several years supports operating scale, broader patient access and stronger utilization potential beyond a single reporting period.
Deleveraged Balance SheetLower leverage improves financial resilience and reduces funding pressure as the company expands diagnostic capacity. The stronger equity base also provides more flexibility to absorb investment needs or operating volatility.
Positive Operating Cash FlowPositive operating cash generation shows that core diagnostic operations are producing cash to support day-to-day activity. This provides an internal funding base, even though expansion spending and working capital limit free cash flow.
Bears Say
Persistently Negative Free Cash FlowRepeatedly negative free cash flow indicates that investment requirements or working-capital needs consume operating cash. If sustained, expansion may require additional funding and could constrain financial flexibility despite the improved balance sheet.
Volatile ProfitabilityProfit volatility makes earnings less predictable and complicates long-term planning. Inconsistent margins may reflect changing service mix, pricing or operating costs, limiting confidence that recent earnings recovery will remain durable.
Weak Cash ConversionWeak cash conversion reduces the quality of reported earnings because profits are not consistently translating into liquidity. This can increase reliance on balance-sheet capacity or external funding to finance ongoing operations and growth.
Krsnaa Diagnostics Limited News
KRSNAA FAQ
What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹891.80 in the past 12 months.
What is Krsnaa Diagnostics Limited’s market cap?
Krsnaa Diagnostics Limited’s market cap is ₹18.11B.
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
Krsnaa Diagnostics Limited’s upcoming earnings report date is Nov 05, 2026 which is in 42 days.
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Krsnaa Diagnostics Limited released its earnings results on Aug 13, 2026. The company reported ₹5.15 earnings per share for the quarter, missing the consensus estimate of ₹6.15 by -₹1.
Is Krsnaa Diagnostics Limited overvalued?
According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.36%. See more information on Krsnaa Diagnostics Limited dividends here
What is Krsnaa Diagnostics Limited’s EPS estimate?
Krsnaa Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Krsnaa Diagnostics Limited reported an EPS of ₹5.15 in its last earnings report, missing expectations of ₹6.15. Following the earnings report the stock price went down -4.013%.
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:KRSNAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.
Technical Analysis
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―
Vijaya Diagnostic Centre Ltd.
―